SYSTEMIC SCLERODERMA
Clinical trials for SYSTEMIC SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLERODERMA trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug firsekibart tested for scleroderma skin hardening
Disease control Not yet recruitingThis study tests a new drug called firsekibart in 30 adults with a severe form of systemic sclerosis (scleroderma) that affects the skin. The goal is to see if the drug can reduce skin thickening and improve overall disease control. Participants will receive the drug and be compa…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 15, 2026 18:57 UTC
-
Can fat stem cells soften the stiff mouth of scleroderma? new trial aims to find out.
Symptom relief Not yet recruitingThis study tests whether injections of donor stem cells around the mouth can reduce fibrosis and improve daily function in 50 adults with systemic scleroderma who have limited mouth opening. Participants will receive either stem cells or a placebo, and researchers will measure ch…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 12, 2026 12:03 UTC
-
Scientists hunt for rogue immune cells in autoimmune diseases
Knowledge-focused Not yet recruitingThis study aims to better understand why some people's immune cells attack their own body, causing autoimmune diseases like lupus and scleroderma. Researchers will analyze blood samples from 200 adults with these conditions to identify and measure specific harmful immune cells. T…
Matched conditions: SYSTEMIC SCLERODERMA
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC